Your browser doesn't support javascript.
loading
The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice.
Sattar, Naveed A; Ginsberg, Henry; Ray, Kausik; Chapman, M John; Arca, Marcello; Averna, Maurizio; Betteridge, D John; Bhatnagar, Deepak; Bilianou, Elena; Carmena, Rafael; Ceska, Richard; Corsini, Alberto; Erbel, Raimund; Flynn, Paul D; Garcia-Moll, Xavier; Gumprecht, Janusz; Ishibashi, Shun; Jambart, Selim; Kastelein, John J P; Maher, Vincent; da Silva, Pedro Marques; Masana, Luis; Odawara, Masato; Pedersen, Terje R; Rotella, Carlo Maria; Salti, Ibrahim; Teramoto, Tamio; Tokgozoglu, Lale; Toth, Peter P; Valensi, Paul; Vergès, Bruno.
Afiliación
  • Sattar NA; Institute of Cardiovascular & Medical Sciences, BHF Glasgow Cardiovascular Research Centre, University Of Glasgow, 126 University Place, Glasgow G12 8TA, UK. Electronic address: naveed.sattar@glasgow.ac.uk.
  • Ginsberg H; Irving Institute for Clinical and Translational Research, PH 10-305, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. Electronic address: hng1@columbia.edu.
  • Ray K; Cardiovascular Sciences Research Centre, St Georges University of London, Cranmer Terrace, London SW17 0RE, UK. Electronic address: kray@sgul.ac.uke.
  • Chapman MJ; Dyslipidemia and Atherosclerosis Research Unit, INSERM UMR-S939, Pitie-Salpetriere University Hospital, 75651 Paris, France. Electronic address: john.chapman@upmc.fr.
  • Arca M; Department of Internal Medicine and Allied Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Rome, Italy. Electronic address: marcelloarca@libero.it.
  • Averna M; Dept. of Internal Medicine and Medical Specialties, School of Medicine, University of Palermo, Italy. Electronic address: maurizio.averna@unipa.it.
  • Betteridge DJ; University College London, Middlesex Hospital, London, UK. Electronic address: rmhajbe@ucl.ac.uk.
  • Bhatnagar D; Diabetes Centre, The Royal Oldham Hospital, Rochdale Road, Oldham, UK. Electronic address: deepak.bhatnagar@manchester.ac.uk.
  • Bilianou E; Lipid Clinic, Cardiology Department, Tzanio Hospital, Pireas, Greece. Electronic address: elenib1@otenet.gr.
  • Carmena R; Department of Medicine, University of Valencia, Spain. Electronic address: Rafael.Carmena@uv.es.
  • Ceska R; Center of Preventive Cardiology, IIIrd Dept. Int. Med. Charles University and University General Hospital, Prague, Czech Republic. Electronic address: richard.ceska@vfn.cz.
  • Corsini A; Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. Electronic address: alberto.corsini@unimi.it.
  • Erbel R; Department of Cardiology, West German Heart Centre, University of Essen, Germany. Electronic address: Raimund.Erbel@uk-essen.de.
  • Flynn PD; The Lipid Clinic, Box 153, Addenbrooke's Hospital, Cambridge CB0 2QQ, UK. Electronic address: pdf21@cam.ac.uk.
  • Garcia-Moll X; Unitat Hospitalització, Servei de Cardiologia, Hospital de la Santa Creu i Sant Pau, Spain. Electronic address: XGarcia-Moll@santpau.cat.
  • Gumprecht J; Katedra i Klinika Chorób Wewetrznych, Diabetologii i Nefrologii, Slaski Uniwersytet Medyczny, Katowice, Poland. Electronic address: jgumprecht@sum.edu.pl.
  • Ishibashi S; Department of Internal Medicine, Division of Endocrinology and Metabolism, Jichi Medical University, 3311-1, Yakushiji Shimotsuke-shi, Tochigi 329-0498, Japan. Electronic address: ishibash@jichi.ac.jp.
  • Jambart S; St-Joseph University Faculty of Medicine, and Head, Endocrinology and Metabolism Division, Hotel-Dieu de France Hospital, Beirut, Lebanon. Electronic address: sjambart@dm.net.lb.
  • Kastelein JJ; Academic Medical Center/University of Amsterdam, Dept. of Vascular Medicine, F4-159.2, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: j.j.kastelein@amc.uva.nl.
  • Maher V; Department of Cardiology, Tallaght Hospital, Dublin, Ireland. Electronic address: vmaher@gmail.com.
  • da Silva PM; Arterial Investigation Unit, Medicine IV, Santa Marta's Hospital, CHLC, Lisboa, Portugal. Electronic address: pedro.silva@hsmarta.min-saude.pt.
  • Masana L; Unitat de Recerca en Lipids i Arteriosclerosi, IISPV, CIBERDEM, Universitat Rovira i Virgili, Sant Llorenç, 21, 43201 Reus, Spain. Electronic address: luis.masana@urv.cat.
  • Odawara M; Division of Diabetology, Endocrinology and Metabolism, The Third Department of Internal Medicine, Tokyo Medical University, 6-7-1, Nisi-shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Electronic address: odawara@tokyo-med.ac.jp.
  • Pedersen TR; University of Oslo and Oslo University Hospital, Ullevål Centre of Preventive Medicine, Medical Clinic, Oslo, Norway. Electronic address: t.r.pedersen@medisin.uio.no.
  • Rotella CM; Department of Endocrinology, University of Florence Medical School, Italy. Electronic address: c.rotella@dfc.unifi.it.
  • Salti I; Division of Endocrinology and Metabolism, American University of Beirut, Lebanon. Electronic address: isalti@aub.edu.lb.
  • Teramoto T; Teikyo University, Teikyo Academic Research Center, Japan. Electronic address: ttera@med.teikyo-u.ac.jp.
  • Tokgozoglu L; Professor of Cardiology, Hacettepe University, Çankaya, Ankara, Turkey. Electronic address: lalet@hacettepe.edu.tr.
  • Toth PP; University of Illinois College of Medicine, Peoria, IL, USA. Electronic address: peter.toth@cghmc.com.
  • Valensi P; Department of Endocrinology Diabetology Nutrition, APHP, CRNH-IdF, CINFO, Paris Nord University, Bondy, France. Electronic address: paul.valensi@jvr.aphp.fr.
  • Vergès B; Service Endocrinologie, Diabétologie et Maladies Métaboliques, University Hospital Dijon, France. Electronic address: bruno.verges@chu-dijon.fr.
Atheroscler Suppl ; 15(1): 1-15, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24840509
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Prediabético / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Atheroscler Suppl Asunto de la revista: ANGIOLOGIA Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Prediabético / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Diabetes Mellitus Tipo 2 / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Atheroscler Suppl Asunto de la revista: ANGIOLOGIA Año: 2014 Tipo del documento: Article